Transvenous versus subcutaneous implantable cardioverter defibrillator for hypertrophic cardiomyopathy: A meta-analysis

Transvenous versus subcutaneous implantable cardioverter defibrillator for hypertrophic cardiomyopathy: A meta-analysis

Saved in:

Bibliographic Details
Main Authors:	Xi Yang, Yanwei Wang, Kejun Xu
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958425005822
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Taghi Hedayati Goudarzi, et al.
Published: (2023-01-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
by: Rifqi Rizkani Eri, et al.
Published: (2025-08-01)

Clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy with indications for implantable cardioverter-defibrillator
by: V. G. Davydova, et al.
Published: (2024-12-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Modified procedures of subcutaneous implantable cardioverter defibrillator implantation for a child with small body size
by: Satoshi Oka, et al.
Published: (2024-02-01)

A Pregnancy with Severe Hypertrophic Obstructive Cardiomyopathy after Surgery for an Implantable Cardioverter Defibrillator: A Case Report and Literature Review
by: Takashi Mitsui, et al.
Published: (2016-01-01)

Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)

Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment
by: Altaf Hussain Shah, et al.
Published: (2015-07-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy
by: Naoya Kataoka, et al.
Published: (2025-08-01)

How to indicate implantable cardioverter‐defibrillator in the aging population
by: Risako Orita, et al.
Published: (2025-04-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming
by: Tatiana Pavlenko, et al.
Published: (2024-12-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Relapsed Brucellosis Manifested as Endocarditis with Vegetation on the Implantable Cardioverter Defibrillator Lead
by: Bisher Sawaf, et al.
Published: (2021-01-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

CRO-INSIGHT: Utilization of Implantable Cardioverter Defibrillators in Non-ischemic and Ischemic Cardiomyopathy in a Single Croatian Tertiary Hospital Centre
by: Mislav Puljevic, et al.
Published: (2025-04-01)

A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease
by: Т. A. Atabekov, et al.
Published: (2019-04-01)

Perioperative Management of Pacemakers (PM) and Implantable Cardioverter Defibrillators (ICD) in South Africa
by: A. Keene
Published: (2019-04-01)

Life-Threatening Coronary Vasospasm Treated by Implantable Cardioverter Defibrillator: The Warning Signs
by: Deborah Adepoju, et al.
Published: (2022-01-01)

First Reported Case of Candida dubliniensis Endocarditis Related to Implantable Cardioverter-Defibrillator
by: Nooraldin Merza, et al.
Published: (2020-01-01)

Social Determinants of Health‐Related Outcomes in an Intervention Following Initial Implantable Cardioverter‐Defibrillator Implantation
by: Megan M. Streur, et al.
Published: (2025-05-01)

Serratia marcescens: A Rare Cause of Recurrent Implantable Cardioverter Defibrillator Site Infection
by: S. Hawkey, et al.
Published: (2015-01-01)

Implantable Cardioverter‐Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto
by: Salvatore Savona, et al.
Published: (2024-08-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
by: Steven H Back, et al.
Published: (2019-01-01)

Implantable cardioverter defibrillator - powerful weapon in primary and secondary prevention of sudden cardiac death
by: Kostić Tomislav, et al.
Published: (2019-01-01)

Biotronik Implantable Cardioverter Defibrillator for Measurement of Intrathoracic Impedance: A Report of Two Cases
by: Xuqing Ying, et al.
Published: (2024-11-01)

Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis.
by: David Conen, et al.
Published: (2016-01-01)

Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators
by: Carmelo La Greca, et al.
Published: (2025-08-01)

A closed-loop spinal cord stimulation system in a patient with an implantable cardioverter defibrillator
by: Estefanía Romero-Serrano, et al.
Published: (2025-08-01)